Eleven-Year Prognostic Value of Dobutamine Stress 99mTc-Sestamibi Myocardial Perfusion Imaging in Patients With Limited Exercise Capacity

被引:12
|
作者
Boiten, Hendrik J. [1 ]
van Domburg, Ron T. [1 ]
Valkema, Roelf [2 ]
Schinkel, Arend F. L. [1 ]
机构
[1] Erasmus MC, Thoraxctr, Dept Cardiol, Rotterdam, Netherlands
[2] Erasmus MC, Thoraxctr, Dept Nucl Med, Rotterdam, Netherlands
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2015年 / 115卷 / 07期
关键词
CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; RISK STRATIFICATION; SESTAMIBI SPECT;
D O I
10.1016/j.amjcard.2015.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myocardial perfusion single-photon emission computed tomography is a routine technique for the evaluation of coronary artery disease. However, information on the very long term prognostic value of dobutamine stress single-photon emission computed tomographic myocardial perfusion imaging (MPI) in patients with limited exercise capacity is scarce. The aim of this study was to assess the long-term prognostic value of dobutamine stress technetium-99m (Tc-99m) sestamibi MPI in these patients. The study population consisted of a high-risk cohort of 531 consecutive patients with limited exercise capacity who underwent dobutamine stress Tc-99m-sestamibi MPI for the assessment of known or suspected coronary artery disease. Follow-up was successful in 528 patients. Because of early revascularization, 55 patients were excluded. The present data are based on 473 patients. The end points were all-cause mortality, cardiac death, nonfatal myocardial infarction, and late (>60 days) coronary revascularization. Kaplan-Meier survival curves were performed and univariate and multivariate analyses were performed to identify predictors of very long term outcome. The mean age of the patients was 61 +/- 12 years, and 58% were men. Abnormal results (defined as the presence of reversible or fixed defects) were observed in 312 patients (66%). During a mean follow-up period of 11.3 +/- 6.7 years, 287 patients (61%) died (all-cause mortality), of whom 125 (26%) died due to cardiac causes. Nonfatal myocardial infarction occurred in 59 patients (12%). Late coronary revascularization was performed in 61 patients (13%). Univariate predictors of major cardiac events included age, male gender, previous infarction, diabetes mellitus, history of angina, heart failure, ST-segment changes, abnormal results on Tc-99m-sestamibi scan, reversible defect, fixed defect, summed rest score, and summed stress score. Multivariate analysis identified abnormal results on MPI as a strong independent predictor of major adverse cardiac events. In conclusion, in patients with limited exercise capacity, dobutamine stress Tc-99m-sestamibi single-photon emission computed tomography provides incremental prognostic information in addition to clinical and stress test parameters for the prediction of very long term outcomes. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:884 / 889
页数:6
相关论文
共 50 条
  • [21] Cardiac stress imaging for the prediction of very long-term outcomes: Dobutamine stress echocardiography or dobutamine 99mTc-sestamibi SPECT?
    Boiten, Hendrik J.
    van Domburg, Ron T.
    Geleijnse, Marcel L.
    Valkema, Roelf
    Zijlstra, Felix
    Schinkel, Arend F. L.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2018, 25 (02) : 471 - 479
  • [22] Iloprost-induced variations of myocardial perfusion in SSc patients 99mTc-SESTAMIBI myocardial perfusion evaluation and comparison with dipyridamole stress testing
    Ronga, G
    Montesano, T
    Banci, M
    Farina, G
    Rosato, E
    De Santis, M
    Salsano, F
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1071 - 1071
  • [23] Assessment of myocardial perfusion by harmonic power Doppler imaging at rest and during adenosine stress comparison with 99mTc-Sestamibi SPECT imaging
    Heinle, SK
    Noblin, J
    Goree-Best, P
    Mello, A
    Ravad, G
    Mull, S
    Mammen, P
    Grayburn, PA
    CIRCULATION, 2000, 102 (01) : 55 - 60
  • [24] Transient multifocal pulmonary uptake of 99mTc-sestamibi in myocardial perfusion imaging: Iatrogenic clot artifact
    Hadi Malek
    Nahid Yaghoobi
    Journal of Nuclear Cardiology, 2022, 29 : 2724 - 2727
  • [25] A potential artifact to consider when performing 99mTc-sestamibi myocardial perfusion SPECT imaging in patients with multiple myeloma
    Baghdadi, Yaser
    Di Dea, Mario T.
    Moadel, Renee M.
    Travin, Mark I.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (06) : 3543 - 3545
  • [26] A potential artifact to consider when performing 99mTc-sestamibi myocardial perfusion SPECT imaging in patients with multiple myeloma
    Yaser Baghdadi
    Mario T. Di Dea
    Renée M. Moadel
    Mark I. Travin
    Journal of Nuclear Cardiology, 2022, 29 : 3543 - 3545
  • [27] Personalization of 99mTc-sestamibi activity in SPECT/CT myocardial perfusion imaging with the cardiofocal SmartZoom® collimator
    Emilie Verrecchia-Ramos
    Olivier Morel
    Valérie Beauchat
    Sylvie Denet
    Abdourahamane Djibo Sidikou
    Merwan Ginet
    Estelle Pfletschinger
    Luminita Teodor
    Maud Trombowsky
    Jeany Verdier
    Christelle Vère
    Paul Retif
    Sinan Ben Mahmoud
    EJNMMI Physics, 10
  • [28] Transient multifocal pulmonary uptake of 99mTc-sestamibi in myocardial perfusion imaging: Iatrogenic clot artifact
    Malek, Hadi
    Yaghoobi, Nahid
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (05) : 2724 - 2727
  • [29] Personalization of 99mTc-sestamibi activity in SPECT/CT myocardial perfusion imaging with the cardiofocal SmartZoom® collimator
    Verrecchia-Ramos, Emilie
    Morel, Olivier
    Beauchat, Valerie
    Denet, Sylvie
    Sidikou, Abdourahamane Djibo
    Ginet, Merwan
    Pfletschinger, Estelle
    Teodor, Luminita
    Trombowsky, Maud
    Verdier, Jeany
    Vere, Christelle
    Retif, Paul
    Ben Mahmoud, Sinan
    EJNMMI PHYSICS, 2023, 10 (01)
  • [30] Suitability of 99mTc-teboroxime CZT SPECT for quantitative myocardial perfusion imaging - comparison with 99mTc-sestamibi in mice.
    Thackeray, James
    Wittneben, Alexander
    Wang, Yong
    Wollert, Kai
    Ross, Tobias
    Bengel, Frank
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57